Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $18,168 - $20,851
-240 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$74.21 - $87.6 $17,810 - $21,024
240 New
240 $19,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gfi Investment Counsel Ltd. Portfolio

Follow Gfi Investment Counsel Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gfi Investment Counsel Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gfi Investment Counsel Ltd. with notifications on news.